Table 1 Baseline characteristics of the study
Clinical characteristics | n = 504 |
|---|---|
Age (years) | 76 (70–81) |
Male Sex, n (%) | 260 (51.5) |
course of disease (years) | 6 (2–15) |
Follow-up date (days) | 683 (440.5–730) |
NYHA Class, n (%) | |
II | 76 (15) |
III | 230 (45.6) |
IV | 198 (39.2) |
LVEF, n (%) | |
≥ 50% | 175 (34.7) |
40–49% | 211(41.9) |
< 40% | 118 (23.4) |
BUN (mmol/L) | 6.9 (5.3–9.1) |
Creatinine (μmol/L) | 91 (72–113) |
BUN/Scr | 18.5 (15.0–23.5) |
eGFR(ml/min/1.73 m2) | 63.9 (48.6–79.0) |
Comorbidities, n (%) | |
Coronary heart disease | 420 (83.3) |
Diabetes | 189 (37.5) |
Hypertension | 373 (74) |
Hyperlipidaemia | 280 (55.5) |